Beta Bionics, Inc.
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| – | – | – | – | |
| – | +0.2% | +9.2% | +25.9% | |
| – | -7.2% | +12.8% | +156.6% | |
| – | – | – | – | |
| – | -47.9% | +744.5% | +56.0% | |
| – | +8,962.8% | -95.0% | +4,583.7% | |
| – | +77.9% | -45.0% | +286.4% | |
| – | – | – | -70.4% | |
| – | – | – | – |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.